TherapeuticsMD (TXMD) Total Debt (2011 - 2022)

TherapeuticsMD has reported Total Debt for 8 years, with the latest figure at $93.6 million in Q3 2022.

• For the quarter ending Q3 2022, Total Debt fell 49.88% year-over-year to $93.6 million; the trailing twelve-month figure through Sep 2022 stood at $93.6 million (down 49.88% YoY), and the FY2021 full-year result was $188.3 million, down 20.79% from the prior year.
• Total Debt for Q3 2022 stood at $93.6 million, up from $90.8 million in the prior quarter.
• The five-year high for Total Debt was $243.8 million in Q2 2020, with the low at $73.1 million in Q2 2018.
• Historically, Total Debt has averaged $165.0 million across 5 years, with a median of $187.5 million in 2021.
• Annual changes were most pronounced in 2020 — Total Debt jumped 231.19% — and 2022, when it plunged 51.0%.
• TherapeuticsMD's Total Debt stood at $73.4 million in 2018, then soared by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020, then declined by 20.79% to $188.3 million in 2021, then tumbled by 50.28% to $93.6 million in 2022.
• The last three Total Debt figures came in at $93.6 million (Q3 2022), $90.8 million (Q2 2022), and $202.9 million (Q1 2022), per Business Quant data.